Huapont Life Sciences subsidiary obtained the registration certificate for the cream product of mometasone furoate.

Huapont Life Sciences (002004.SZ) announced that its wholly-owned subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd. (referred to as "Huabang Pharmaceutical"), recently received two specifications of the "Drug Registration Certificate" for its clobetasone butyrate cream approved and issued by the National Medical Products Administration. Clobetasone butyrate cream is mainly used for eczema, neurodermatitis, atopic dermatitis, and itching.